The circulating and tissue RAAS of EH complicated withcardiovascular risk (i.e., dyslipidemia) are excessively activated [45], but genetic ACE2 mutation promotes thedevelopment of atherosclerosis and left heart remodeling [46, 47]. The gene discussed is ACE2; the disease is atherosclerosis.